Skip to content

Platelet Rich Fibrin Versus Melatonin Around Dental Implants

Evaluation of Local Delivered Platelet Rich Fibrin Versus Melatonin Gel on the Osseointegration of Dental Implant. A Randomized Controlled Clinical Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05593731
Enrollment
30
Registered
2022-10-25
Start date
2021-12-10
Completion date
2022-08-10
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Missing Teeth

Brief summary

Dental implant is a dental treatment that allow oral rehabilitation for partial and fully edentulous patients. Osteointegration is the factor that control success s or failure of dental implant that can be improved by addition of different adjunctive biological materials. Platelets Rich fibrin plays a significant role in tissue regeneration and wound healing. Melatonin is biological hormone that secreted from pineal gland and played an important role in human growth.

Interventions

BIOLOGICALdental implants with melatonin gel

platelet rich fibrin membrane around dental implants

Sponsors

Misr University for Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. good oral hygiene participants, 2. free of any systemic diseases, 3. Patients' age ranged from 20 to 40 years old. 4. Patients who can complete surgery and the study protocol. 5. Partially edentulous patients in the posterior mandibular region (at least a single-mandibular edentulous area) with periodontal health.

Exclusion criteria

1. patients who had parafunctional habits, 2. current and former smokers, pregnant 3. lactating women 4. unmotivated patients 5. patients with psychological problems 6. patients who were not able to follow the treatment protocol -

Design outcomes

Primary

MeasureTime frame
gingival thickness6 months

Secondary

MeasureTime frame
bone density6 months
marginal bone loss6 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026